| (210) | Number of the EPO application | 19199101 |
| (220) | Filing date of the EPO application | 2015.12.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 36/2021, 2021.09.08 |
| (110) | EPO patent number | 3626729 |
| (11) | Number of the document | MD 3626729 T2 |
| (21) | Number of the application | e 2020 0298 |
| (71) | Name(s) of applicant(s), code of the country | immatics Biotechnologies GmbH, DE; |
| (72) | Name(s) of inventor(s), code of the country | WEINSCHENK Toni, DE;
MAHR Andrea, DE;
FRITSCHE Jens, DE;
MÜLLER Phillip, DE;
WIEBE Anita, DE;
MISSEL Sarah, DE; |
| (73) | Name(s) of owner(s), code of the country | IMMATICS Biotechnologies GmbH, DE; |
| (54) | Title of the invention | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 7/08 (2006.01.01); A61K 38/04 (2006.01.01); A61K 39/00 (2006.01.01) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2020.04.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.12.31 |
| (30) | Priority | 201423016, 2014.12.23, GB; 201462096165 P, 2014.12.23, US; 201501017, 2015.01.21, GB |
| (74) | Patent attorney | (Procedură) FOCŞA Valentin, bd. Renaşterii Naţionale, No. 6, of. 08, MD-2024, mun. Chişinău, Republica Moldova |